Cargando…

Telbivudine in chronic lymphocytic myocarditis and human parvovirus B19 transcriptional activity

AIMS: Myocarditis is often associated with parvovirus B19 (B19V) persistence, which can induce vascular damage. Based on the antiviral and anti‐inflammatory properties of telbivudine, we aimed to evaluate its efficacy to protect B19V‐infected endothelial cells in vitro and to treat chronic lymphocyt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Van Linthout, Sophie, Elsanhoury, Ahmed, Klein, Oliver, Sosnowski, Marzena, Miteva, Kapka, Lassner, Dirk, Abou‐El‐Enein, Mohamed, Pieske, Burkert, Kühl, Uwe, Tschöpe, Carsten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165949/ https://www.ncbi.nlm.nih.gov/pubmed/30099854 http://dx.doi.org/10.1002/ehf2.12341

Ejemplares similares

Telbivudine Reduces Parvovirus B19-Induced Apoptosis in Circulating Angiogenic Cells
por: Zobel, Thomas, et al.
Publicado: (2019)

Apolipoprotein A-I gene transfer exerts immunomodulatory effects and reduces vascular inflammation and fibrosis in ob/ob mice
por: Spillmann, Frank, et al.
Publicado: (2016)

Mesenchymal Stromal Cells Modulate Monocytes Trafficking in Coxsackievirus B3‐Induced Myocarditis
por: Miteva, Kapka, et al.
Publicado: (2017)

The Spontaneous Course of Human Herpesvirus 6 DNA-Associated Myocarditis and the Effect of Immunosuppressive Intervention
por: Elsanhoury, Ahmed, et al.
Publicado: (2022)

Immunomodulatory Effects of Mesenchymal Stromal Cells Revisited in the Context of Inflammatory Cardiomyopathy
por: Miteva, Kapka, et al.
Publicado: (2013)

Mechanical Unloading by Fulminant Myocarditis: LV-IMPELLA, ECMELLA, BI-PELLA, and PROPELLA Concepts
por: Tschöpe, Carsten, et al.
Publicado: (2018)

Colchicine prevents disease progression in viral myocarditis via modulating the NLRP3 inflammasome in the cardiosplenic axis
por: Pappritz, Kathleen, et al.
Publicado: (2022)

Mesenchymal stromal cells inhibit NLRP3 inflammasome activation in a model of Coxsackievirus B3-induced inflammatory cardiomyopathy
por: Miteva, Kapka, et al.
Publicado: (2018)

Targeting CD20+ B-lymphocytes in inflammatory dilated cardiomyopathy with rituximab improves clinical course: a case series
por: Tschöpe, Carsten, et al.
Publicado: (2019)

A Toolbox of Potential Immune-Related Therapies for Inflammatory Cardiomyopathy
por: Elsanhoury, Ahmed, et al.
Publicado: (2020)

Cardiac (myo)fibroblasts modulate the migration of monocyte subsets
por: Pappritz, Kathleen, et al.
Publicado: (2018)

Cardiac Migration of Endogenous Mesenchymal Stromal Cells in Patients with Inflammatory Cardiomyopathy
por: Schmidt-Lucke, Caroline, et al.
Publicado: (2015)

Reversible transition from a hypertrophic to a dilated cardiomyopathy
por: Spillmann, Frank, et al.
Publicado: (2015)

Human Cardiac-Derived Adherent Proliferating Cells Reduce Murine Acute Coxsackievirus B3-Induced Myocarditis
por: Miteva, Kapka, et al.
Publicado: (2011)

Mode-of-action of the PROPELLA concept in fulminant myocarditis
por: Spillmann, Frank, et al.
Publicado: (2019)

Viral myocarditis: a prime example for endomyocardial biopsy-guided diagnosis and therapy
por: Van Linthout, Sophie, et al.
Publicado: (2018)

Mesenchymal Stromal Cells but Not Cardiac Fibroblasts Exert Beneficial Systemic Immunomodulatory Effects in Experimental Myocarditis
por: Savvatis, Konstantinos, et al.
Publicado: (2012)

Wearable cardioverter‐defibrillator: friend or foe in suspected myocarditis?
por: Blaschke, Florian, et al.
Publicado: (2021)

Epicardial Fat Expansion in Diabetic and Obese Patients With Heart Failure and Preserved Ejection Fraction—A Specific HFpEF Phenotype
por: Elsanhoury, Ahmed, et al.
Publicado: (2021)

SARS‐CoV‐2‐related myocarditis‐like syndromes Shakespeare's question: what's in a name?
por: Van Linthout, Sophie, et al.
Publicado: (2020)

Modulation of the acute defence reaction by eplerenone prevents cardiac disease progression in viral myocarditis
por: Tschöpe, Carsten, et al.
Publicado: (2020)

Serum alarmin S100A8/S100A9 levels and its potential role as biomarker in myocarditis
por: Müller, Irene, et al.
Publicado: (2020)

High Perforin‐Positive Cardiac Cell Infiltration and Male Sex Predict Adverse Long‐Term Mortality in Patients With Inflammatory Cardiomyopathy
por: Escher, Felicitas, et al.
Publicado: (2017)

Placenta‐Derived Adherent Stromal Cells Improve Diabetes Mellitus‐Associated Left Ventricular Diastolic Performance
por: Van Linthout, Sophie, et al.
Publicado: (2017)

Treatment of Transthyretin Amyloid Cardiomyopathy: The Current Options, the Future, and the Challenges
por: Tschöpe, Carsten, et al.
Publicado: (2022)

Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditis
por: Van Linthout, S., et al.
Publicado: (2011)

Diagnostic value of cardiovascular magnetic resonance in comparison to endomyocardial biopsy in cardiac amyloidosis: a multi-centre study
por: Chatzantonis, Grigorios, et al.
Publicado: (2020)

QRS fragmentation as a possible electrocardiographic diagnostic marker in patients with acute myocarditis: preliminary histopathological validation
por: Ferrero, Paolo, et al.
Publicado: (2020)

Myeloid-Derived Suppressor Cells Restrain Natural Killer Cell Activity in Acute Coxsackievirus B3-Induced Myocarditis
por: Müller, Irene, et al.
Publicado: (2021)

Impact of Syndecan-2-Selected Mesenchymal Stromal Cells on the Early Onset of Diabetic Cardiomyopathy in Diabetic db/db Mice
por: Pappritz, Kathleen, et al.
Publicado: (2021)

New Echocardiographic Findings Correlate with Intramyocardial Inflammation in Endomyocardial Biopsies of Patients with Acute Myocarditis and Inflammatory Cardiomyopathy
por: Escher, Felicitas, et al.
Publicado: (2013)

COVID-19 vs. Classical Myocarditis Associated Myocardial Injury Evaluated by Cardiac Magnetic Resonance and Endomyocardial Biopsy
por: Tanacli, Radu, et al.
Publicado: (2021)

Accelerating Patients’ Access to Advanced Therapies in the EU
por: Elsanhoury, Ahmed, et al.
Publicado: (2017)

Parvovirus B19 Myocarditis of Fulminant Evolution
por: Spartalis, Michael, et al.
Publicado: (2017)

New Insights in (Inter)Cellular Mechanisms by Heart Failure with Preserved Ejection Fraction
por: Tschöpe, Carsten, et al.
Publicado: (2014)

Inflammation – Cause or Consequence of Heart Failure or Both?
por: Van Linthout, Sophie, et al.
Publicado: (2017)

Immunosuppressive treatment in fulminant myocarditis and gene expression pattern associated with, but no histological confirmation of giant cell myocarditis
por: Fruhwald, Friedrich, et al.
Publicado: (2017)

Down-regulation of endothelial TLR4 signalling after apo A-I gene transfer contributes to improved survival in an experimental model of lipopolysaccharide-induced inflammation
por: Van Linthout, Sophie, et al.
Publicado: (2010)

Sex- and age-related differences in the inflammatory properties of cardiac fibroblasts: impact on the cardiosplenic axis and cardiac fibrosis
por: Pappritz, Kathleen, et al.
Publicado: (2023)

Clinicopathological Features of Telbivudine-Associated Myopathy
por: Ambang, Tomica, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_l1gauuvjer5rcmjg08oita1glu